Where does Dermira, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Dermira, Inc. ranks #20,998 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Dermira, Inc. hold?

Dermira, Inc. holds 13 US utility patents granted between 2015 and 2021, spanning 8 technology areas.

What is Dermira, Inc.'s Innovation Score?

Dermira, Inc. has an Innovation Score of 34.1 out of 100 (47th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Dermira, Inc. focus on?

Dermira, Inc.'s top technology area is C07D (Heterocyclic Compounds) with 13 patents, ranking #636 of 3,165 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Dermira, Inc.'s patent grant rate increasing or decreasing?

Dermira, Inc.'s recent grant velocity is -70% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Dermira, Inc.'s patents?

Dermira, Inc.'s patents average 26.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Dermira, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Dermira, Inc.

USPTO PatentsView assignee record - 13 granted patents across 8 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Dermira ranks #20,998 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 8 technology areas.

#20,998
of 49,997 US assignees by volume: 47th percentile
by Innovation Score (34.1/100): 26.8
avg claims per patent: -70%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20998 · US Corporation #20,998 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #20,998/49,997
PHOTO-FINISH Dee Zee
CPC-NARROW C07D · 8 areas
INNOV-THIN 34.1/100
CLAIMS-DENSE 26.8 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -70% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Dee Zee, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Dermira’s 34.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.1 pts (27%) Velocity 0.0 pts (0%) Breadth 10.0 pts (29%) Claim depth 15.0 pts (44%)

Qualcomm Incorporated · highest

85
Dermira · this assignee

34
3D Lighting… · lowest

7

What this shows Dermira's Innovation Score is 34.1/100 (47th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Dermira?

Each dot is one of Dermira’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Dermira’s own 26.8 claims/patent is ABOVE the 17.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Dermira vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Dermira's grants concentrate

Dermira, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2018 (3 grants) versus a trough of 1 in 2019. By volume, Dermira sits between DeNovo Sciences, Inc. and Digital Turbine, Inc..

Denovo Sciences

13
Dee Zee

13
Deem

13
Delcath Systems

13
Designer Direct

13
Diehl BGT Defence…

13
Digital Asset Cap…

13
Digital Turbine

13
Dermira ◀

13

What this shows Dermira holds 13 patents at rank #21,014, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Dermira

By rank, the assignees closest to #21,014 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Dermira's primary technology class.

Dermira's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 47th percentile higher than 47% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Dermira, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	15.4%
2016	2	15.4%
2017	2	15.4%
2018	3	23.1%
2019	1	7.7%
2020	2	15.4%
2021	1	7.7%

Which technologies does Dermira, Inc. patent most?

C07D - Heterocyclic Compounds 13

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 8

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

C07C - Acyclic OR Carbocyclic Compounds 5

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 2

B01D - Separation 2

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Dermira, Inc.'s patent record in context - here's where to go next.

Dermira, Inc.'s lead technology class is C07D (Heterocyclic Compounds), 100% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #20,998 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Dermira, Inc. against DeNovo Sciences, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.